tiprankstipranks
Trending News
More News >
Piramal Pharma Limited (IN:PPLPHARMA)
:PPLPHARMA
India Market

Piramal Pharma Limited (PPLPHARMA) Financial Statements

Compare
2 Followers

Piramal Pharma Limited Financial Overview

Piramal Pharma Limited's market cap is currently ₹259.27B. The company's EPS TTM is ₹1.275; its P/E ratio is 282.68; and it has a dividend yield of 0.06%. Piramal Pharma Limited is scheduled to report earnings on May 14, 2025, and the estimated EPS forecast is ₹-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 91.51B₹ 81.71B₹ 70.82B₹ 64.72B₹ 29.00B
Gross Profit₹ 59.20B₹ 49.09B₹ 40.81B₹ 37.91B₹ 16.46B
Operating Income₹ 36.12B₹ 4.32B₹ -479.70M₹ 3.65B₹ 4.81B
EBITDA₹ 14.04B₹ 13.67B₹ 8.46B₹ 12.60B₹ 6.11B
Net Income₹ 911.30M₹ 178.20M₹ -1.86B₹ 3.76B₹ 5.71B
Balance Sheet
Cash & Short-Term Investments₹ 5.21B₹ 5.02B₹ 6.60B₹ 3.79B₹ 1.62B
Total Assets₹ 156.78B₹ 153.12B₹ 145.23B₹ 127.97B₹ 57.57B
Total Debt₹ 48.56B₹ 47.10B₹ 56.37B₹ 41.28B₹ 1.74B
Net Debt₹ 43.55B₹ 43.53B₹ 54.41B₹ 39.00B₹ 275.30M
Total Liabilities₹ 75.52B₹ 74.00B₹ 77.49B₹ 61.00B₹ 16.56B
Stockholders' Equity₹ 81.25B₹ 79.11B₹ 67.73B₹ 66.97B₹ 41.01B
Cash Flow
Free Cash Flow₹ 2.28B₹ 2.92B₹ -4.81B₹ -1.23B₹ -233.90M
Operating Cash Flow₹ 8.92B₹ 10.05B₹ 4.84B₹ 7.66B₹ 347.20M
Investing Cash Flow₹ -4.77B₹ -4.56B₹ -13.39B₹ -18.12B₹ -43.83B
Financing Cash Flow₹ -4.41B₹ -4.22B₹ 8.18B₹ 9.06B₹ 44.94B
Currency in INR

Piramal Pharma Limited Earnings and Revenue History

Piramal Pharma Limited Debt to Assets

Piramal Pharma Limited Cash Flow

Piramal Pharma Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis